Trial · NCT06581302
Magnetic Seizure Therapy for Psychotic Disorders
NCT06581302, Not applicable, Recruiting, Shanghai Jiao Tong University School of Medicine
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Magnetic Seizure Therapy for Psychotic Disorders. Trials, record NCT06581302. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06581302
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Magnetic Seizure Therapy for Psychotic Disorders
- NCT number
- NCT06581302
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Conditions
- Psychotic Disorders
- Interventions
- Magnetic seizure therapy by Magnetic stimulator, Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc)
- First posted
- 2024-09-03
- Last updated
- 2025-11-25
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes in Positive and Negative Symptom Scale (PANSS) | Baseline, 1 weeks, 2 weeks, 6 weeks | measured by Positive and Negative Symptom Scale (PANSS) |
| Secondary | Changes in cognition | Baseline, 1 weeks, 2 weeks | measured by MCCB cognition tests |
| Secondary | Changes of ictal EEG feature | during each treatment | measured by electroencephalogram (EEG) |
| Secondary | Changes of cortical inhibition | baseline, 2 weeks | measured by TMS evoked potentials (TEP) |
| Secondary | Changes of brain grey matter | baseline, 2 weeks | measured by structural MRI images of brain |
| Secondary | Changes in 24-item Hamilton Depression Rating Scale (HAM-D) | Baseline, 1 weeks, 2 weeks, 6 weeks | measured by 24-item Hamilton Depression Rating Scale (HAM-D) |
| Secondary | Changes in Hamilton Anxiety Scale (HAMA) | Baseline, 1 weeks, 2 weeks, 6 weeks | measured by Hamilton Anxiety Scale (HAMA) |
| Secondary | Changes in Clinical Global Impression (CGI) scale | Baseline, 2 weeks, 6 weeks | measured by Clinical Global Impression (CGI) scale |
| Secondary | Changes in Global Assessment of Functioning (GAF) scale | Baseline, 2 weeks, 6 weeks | measured by Global Assessment of Functioning (GAF) scale |
| Secondary | Changes in brain gamma band signal | Baseline, 2 weeks | Gamma band signal will be measured by magnetoencephalogram (MEG) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06581302
GET https://conductscience.org/api/trials/v1/NCT06581302/registered